Food News and Research

RSS

Study shows higher levels of phenolic compounds in organic tomatoes

Study conducted at the University of Barcelona shows that organic tomatoes contain higher levels of phenolic compounds than conventional tomatoes. Phenolic compounds are organic molecules found in many vegetables with proven human health benefits.

4 Jul 2012

OraSure Technologies receives FDA approval for new in-home HIV test

The U.S. Food and Drug Administration today approved the OraQuick In-Home HIV Test, the first over-the-counter, self-administered HIV test kit to detect the presence of antibodies to human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2).

4 Jul 2012

Obesity epidemic requires new focus on controlling energy balance and preventing weight gain

As the United States confronts the growing epidemic of obesity among children and adults, a team of University of Colorado School of Medicine obesity researchers concludes that what the nation needs is a new battle plan - one that replaces the emphasis on widespread food restriction and weight loss with an emphasis on helping people achieve "energy balance" at a healthy body weight.

4 Jul 2012

Social interventions may help slow or treat age-related dementia

Scientists at Arizona State University have discovered that older honey bees effectively reverse brain aging when they take on nest responsibilities typically handled by much younger bees.

4 Jul 2012

UPM researchers develop a functional biscuit for celiac patients

Researchers at the Universidad Politécnica de Madrid (UPM) have patented a biscuit which is made from teff flour, suitable for celiac patients, and, thanks to its nutritional properties, it is ideal for sportsmen, diabetics and people with anemia.

4 Jul 2012

FDA approves Abbott’s Healon EndoCoat OVD device

Abbott announced today that it has expanded its Healon family of ophthalmic viscosurgical devices (OVDs) with the U.S. Food and Drug Administration approval of Healon EndoCoat OVD, a device intended for use as a surgical aid in cataract extraction and intraocular lens (IOL) implantation.

4 Jul 2012

FDA approves Lupin’s Norgestimate and Ethinyl Estradiol Tablets

Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. has received approval for its Norgestimate and Ethinyl Estradiol Tablets, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg from the United States Food and Drugs Administration (FDA).

4 Jul 2012

Researchers use mouse model of autism to treat CTD

Using a mouse model of autism, researchers at the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center have successfully treated an autism spectrum disorder characterized by severe cognitive impairment.

3 Jul 2012

First Edition: July 3, 2012

Today's headlines include reports that continue to delve into the policy-oriented and political repercussions of last week's high court decision on the health law.

3 Jul 2012

Study identifies possible new approach to defeat bacterial infections

Research led by St. Jude Children's Research Hospital scientists has identified a possible new approach to defeating bacterial infections by targeting an innate immune system component in a bid to invigorate the immune response.

3 Jul 2012

Cutting funding for international food aid 'not the best answer' to saving money in U.S. budget

In order to "fill food gaps in the 70 most food deficient countries, ... the U.S., through the Food for Peace program and other food aid programs, provides approximately two million tons of American-grown food donations to 50 million starving people every year," James Henry, chair of USA Maritime, writes in an opinion piece in The Hill's "Congress Blog."

3 Jul 2012

FDA accepts BLA filing and grants Priority Review to ThromboGenics' ocriplasmin

ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that it has officially accepted the filing of the Biologics License Application for ocriplasmin intravitreal injection, 2.5 mg/ml and granted it Priority Review.

3 Jul 2012

FDA clears Syneron Medical's elos Plus system

Syneron Medical Ltd., the global leader in medical aesthetic products and technology, announced today that it has received United States Food and Drug Administration (FDA) clearance for elos Plus, a next generation multi-platform system featuring the Company's proprietary elos technology.

2 Jul 2012

FDA approves Roche's new HIV viral load test

Roche announced today that a new HIV viral load test has been approved by the United States Food and Drug Administration (FDA) and will be commercially available in the US later this year.

2 Jul 2012

Rexahn submits RX-5902 IND to FDA for treatment of advanced or metastatic solid tumors

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted an investigational new drug application (IND) to the Food and Drug Administration for a first-in-human study of RX-5902 to treat advanced or metastatic solid tumors.

2 Jul 2012

Janssen seeks accelerated FDA approval for bedaquiline to treat MDR-TB

Janssen Research & Development, LLC today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking accelerated approval for the use of the investigational drug bedaquiline (TMC207) as an oral treatment, to be used as part of combination therapy for pulmonary, multi-drug resistant tuberculosis (MDR-TB) in adults.

2 Jul 2012

Bristol-Myers Squibb to acquire Amylin

Bristol-Myers Squibb Company and Amylin Pharmaceuticals, Inc. announced today that Bristol-Myers Squibb will acquire Amylin for $31.00 per share in cash, pursuant to a cash tender offer and second step merger, or an aggregate purchase price of approximately $5.3 billion.

2 Jul 2012

Secrets to the Danish success in combating antimicrobial resistance

The global consumption of antimicrobial agents for animals is almost twice the size of human consumption. Since the mid-1990s, Denmark has reduced animal consumption of antimicrobial agents by 60% without reducing its agricultural output. In a comment in the journal Nature, Professor Frank Møller Aarestrup, the National Food Institute, Technical University of Denmark, gives his explanation of the success of the Danish efforts.

2 Jul 2012

New toxicology testing method requires lesser number of fish

A new way of testing the safety of natural and synthetic chemicals has been developed by scientists with funding from the Biotechnology and Biological Sciences Research Council (BBSRC). Their research, published today in the journal Ecotoxicology, could reduce the number of fish needed to test the toxicity of a range of chemicals including pharmaceuticals and environmental pollutants.

30 Jun 2012

Big challenges from antibiotic resistant bacteria

Antibiotic resistant bacteria are increasing and spreading at an alarming speed. The bacterial evolution is overwhelming our antibiotic defense. More and more bacteria are becoming resistant to antibiotics resulting in fatal consequences for millions of people. We need common action and responsibility for the development of new effective antibiotics and to stop antibiotic misuse.

30 Jun 2012